Luveniq (voclosporin)
- Region
- 🇪🇺 EU
- Active substance
- voclosporin
- Company
- Lux Biosciences GmbH
- Status
- Application withdrawn
- Therapeutic area
- Uveitis
- Application
- EMEA/H/C/002069
- ATC
- L04AD03
- Official record
- www.ema.europa.eu
Indication
treatment of non-infectious uveitis
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Lupkynis Authorised · Otsuka Pharmaceutical Netherlands B.V.
Follow Luveniq
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.